Suprax patents expiration

Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US9233112 LUPIN LTD Pharmaceutical compositions of cefixime
Dec, 2028

(4 years from now)

Suprax is owned by Lupin Ltd.

Suprax contains Cefixime.

Suprax has a total of 1 drug patent out of which 0 drug patents have expired.

Suprax was authorised for market use on 20 February, 2013.

Suprax is available in for suspension;oral dosage forms.

Suprax can be used as methods for treating bacterial infections.

The generics of Suprax are possible to be released after 14 December, 2028.

Drugs and Companies using CEFIXIME ingredient

Market Authorisation Date: 20 February, 2013

Treatment: Methods for treating bacterial infections


How can I launch a generic of SUPRAX before it's drug patent expiration?
More Information on Dosage

SUPRAX family patents

Family Patents